The use and efficacy of chemotherapy and radiotherapy in children and adults with pilocytic astrocytoma
- PMID: 33131004
- DOI: 10.1007/s11060-020-03653-y
The use and efficacy of chemotherapy and radiotherapy in children and adults with pilocytic astrocytoma
Abstract
Purpose: The aim of this study was to understand the use of chemotherapy (CMT) and radiotherapy (RT) in pilocytic astrocytoma (PA) and their impact on overall survival (OS).
Methods: Data from the National Cancer Database (NCDB) for patients with non-metastatic WHO grade I PA from 2004 to 2014 were analyzed. Pearson's chi-squared test and multivariate logistic regression analyses were performed to assess the distribution of demographic, clinical, and treatment factors. Inverse probability of treatment weighting (IPTW) was used to account for differences in baseline characteristics. Kaplan-Meier analyses and doubly-robust estimation with multivariate Cox proportional hazards modeling were used to analyze OS.
Results: Of 3865 patients analyzed, 294 received CMT (7.6%), 233 received RT (6.0%), and 42 (1.1%) received both. On multivariate analyses, decreasing extent of surgical resection was associated with receipt of both CMT and RT. Brainstem tumors were associated with RT, optic nerve tumors were associated with CMT. Cerebellar tumors were inversely associated with both CMT and RT. Younger age was associated with receipt of CMT; conversely, older age was associated with receipt of RT. After IPTW, receipt of CMT and/or RT were associated with an OS decrement compared with matched patients treated with surgery alone or observation (HR 3.29, p < 0.01).
Conclusions: This is the largest study to date to examine patterns of care and resultant OS outcomes in PA. We identified patient characteristics associated with receipt of CMT and RT. After propensity score matching, receipt of CMT and/or RT was associated with decreased OS.
Keywords: Astrocytoma; Chemotherapy; Pilocytic; Radiotherapy; Survival.
References
-
- Ostrom QT, Gittleman H, Liao P, Vecchione-Koval T, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS (2017) CBTRUS Statistical Report: primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014. Neuro Oncol 19(suppl_5):v1–v88. https://doi.org/10.1093/neuonc/nox158 - DOI - PubMed - PMC
-
- Bornhorst M, Frappaz D, Packer RJ (2016) Pilocytic astrocytomas. Handb Clin Neurol 134:329–344. https://doi.org/10.1016/B978-0-12-802997-8.00020-7 - DOI - PubMed
-
- Colin C, Padovani L, Chappe C, Mercurio S, Scavarda D, Loundou A, Frassineti F, Andre N, Bouvier C, Korshunov A, Lena G, Figarella-Branger D (2013) Outcome analysis of childhood pilocytic astrocytomas: a retrospective study of 148 cases at a single institution. Neuropathol Appl Neurobiol 39(6):693–705. https://doi.org/10.1111/nan.12013 - DOI - PubMed
-
- Kulac I, Tihan T (2019) Pilomyxoid astrocytomas: a short review. Brain Tumor Pathol 36(2):52–55. https://doi.org/10.1007/s10014-019-00343-0 - DOI - PubMed
-
- Amatya VJ, Akazawa R, Sumimoto Y, Takeshima Y, Inai K (2009) Clinicopathological and immunohistochemical features of three pilomyxoid astrocytomas: comparative study with 11 pilocytic astrocytomas. Pathol Int 59(2):80–85. https://doi.org/10.1111/j.1440-1827.2008.02332.x - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
